Anthrax Vaccine Approved for Postexposure ProtectionAnthrax Vaccine Approved for Postexposure Protection

Studies indicate that people receiving BioThrax after a confirmed or suspected exposure to the bacterium that causes the disease may have a 70% chance of surviving. FDA Approvals
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Alert Source Type: news